NCT05218473

Brief Summary

In this prospective, single-center, open-label, non-randomized, single- arm, historically controlled study, we will compare the detection rate of paroxysmal atrial fibrillation in acute ischemic stroke patients without known atrial fibrillation, using 14-day continuous electrocardiography patch monitoring, with a historical control group of patients who received serial 12-lead electrocardiograms once daily for five days or conventional 24-hour Holter monitoring. The study will be conducted in Chang Gung Memorial Hospital at Chiayi, Taiwan, from February 2022 to December 2024.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
150

participants targeted

Target at P50-P75 for not_applicable atrial-fibrillation

Timeline
Completed

Started Feb 2022

Typical duration for not_applicable atrial-fibrillation

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 6, 2022

Completed
26 days until next milestone

First Posted

Study publicly available on registry

February 1, 2022

Completed
20 days until next milestone

Study Start

First participant enrolled

February 21, 2022

Completed
2.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2024

Completed
Last Updated

February 15, 2022

Status Verified

February 1, 2022

Enrollment Period

2.9 years

First QC Date

January 6, 2022

Last Update Submit

February 14, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Paroxysmal atrial fibrillation

    The detection rate (%, percent) of new paroxysmal atrial fibrillation in each arm

    day 14

Study Arms (2)

Prolonged ECG monitoring group

EXPERIMENTAL

Patients receive 14-day continuous electrocardiography patch monitoring

Diagnostic Test: Prolonged ECG monitoring

Conventional procedure group

ACTIVE COMPARATOR

Patients received serial 12-lead electrocardiograms once daily for five days or 24-hour Holter monitoring

Diagnostic Test: Conventional procedure group

Interventions

Using 14-day continuous electrocardiography patch monitoring to increase the detection rate of paroxysmal atrial fibrillation in acute ischemic stroke patients without known atrial fibrillation.

Prolonged ECG monitoring group

Using serial 12-lead electrocardiograms once daily for five days or conventional 24-h Holter monitoring to detect new atrial fibrillation

Conventional procedure group

Eligibility Criteria

Age50 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Acute ischemic stroke defined as an acute episode of neurological dysfunction caused by focal cerebral infarction and/or a corresponding lesion on brain imaging
  • Stroke symptoms within 7 days
  • Age ≥ 50 years
  • At least one 12-lead ECG has already been obtained as part of the routine clinical workup after admisison, and no ECGs have shown any episodes of atrial fibrillation or atrial flutter

You may not qualify if:

  • History of atrial fibrillation/atrial flutter or documented atrial fibrillation/atrial flutter prior to enrollment
  • Intracerebral hemorrhage in medical history
  • Implanted pacemaker device or cardioverter/defibrillator
  • End stage renal disease
  • Endocarditis
  • Untreated hyperthyroidism
  • Myocardial infarction or cardiac surgery less than one month prior to index stroke
  • Any finding on echocardiography for which there is already an evidence-based indication for long-term anticoagulation (e.g. mechanical heart valve, thrombus, etc.)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Atrial FibrillationIschemic Stroke

Condition Hierarchy (Ancestors)

Arrhythmias, CardiacHeart DiseasesCardiovascular DiseasesPathologic ProcessesPathological Conditions, Signs and SymptomsStrokeCerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Model Details: This is an interventional study without concurrent controls. We will compare the detection rate of paroxysmal atrial fibrillation in acute ischemic stroke patients without known atrial fibrillation, using 14-day continuous ECG patch monitoring, with a historical control group of patients who received serial 12-lead ECGs or 24-hour Holter monitoring.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Clinical Professor

Study Record Dates

First Submitted

January 6, 2022

First Posted

February 1, 2022

Study Start

February 21, 2022

Primary Completion

December 31, 2024

Study Completion

December 31, 2024

Last Updated

February 15, 2022

Record last verified: 2022-02